Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 1
1998 1
1999 3
2001 1
2002 3
2005 1
2007 4
2008 2
2009 2
2010 2
2011 4
2012 4
2013 5
2014 3
2015 4
2016 2
2017 3
2019 4
2020 7
2021 4
2022 2
2023 3
2024 3
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trial.
Cavallaro G, Grassi A, Pavoni C, Micò MC, Busca A, Cavattoni IM, Santarone S, Borghero C, Olivieri A, Milone G, Chiusolo P, Musto P, Saccardi R, Patriarca F, Pane F, Saporiti G, Rivela P, Terruzzi E, Cerretti R, Marotta G, Carella AM, Nagler A, Russo D, Corradini P, Bernasconi P, Iori AP, Castagna L, Mordini N, Oldani E, Di Grazia C, Bacigalupo A, Rambaldi A. Cavallaro G, et al. Among authors: oldani e. Blood Cancer J. 2024 Aug 21;14(1):141. doi: 10.1038/s41408-024-01116-5. Blood Cancer J. 2024. PMID: 39168989 Free PMC article. Clinical Trial.
Clinical Impact of Graft Cryopreservation on Allogeneic Stem Cell Transplantation: An Italian, Registry-Based Study on Behalf of the "Gruppo Italiano Per Il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare" (GITMO).
Defrancesco I, Ferretti VV, Chiusolo P, Russo D, Nozzoli C, Olivieri A, Gambella M, Cavattoni IM, Bramanti S, Santarone S, Fanin R, Cairoli R, Piemontese S, Parma M, Onida F, Busca A, Castagna L, Cuoghi A, Pastore D, Mordini N, Benedetti F, Skert C, Borghero C, Iori AP, Fagioli F, Pavone V, Selleri C, Cesaro S, Musso M, Ladetto M, Vallisa D, Carluccio P, Picardi A, Tozzi M, Biffi A, Milone G, Faraci M, Prete A, Prezioso L, Risitano AM, Tambaro FP, Tintori V, Galieni P, Pane F, Zerbi C, Bianchessi A, Losi G, Romano F, Taurino A, Oldani E, Polverelli N, Bonifazi F, Martino M. Defrancesco I, et al. Among authors: oldani e. Am J Hematol. 2025 Aug;100(8):1354-1364. doi: 10.1002/ajh.27731. Epub 2025 Jun 2. Am J Hematol. 2025. PMID: 40456127 Free PMC article.
Donor-specific anti-HLA antibodies (DSAs) in patients undergoing allogeneic hematopoietic stem cell transplantation from mismatched donors on behalf of GITMO and AIBT.
La Rocca U, Ricci R, Piciocchi A, Barberi W, Oldani E, Dominietto A, Cerretti R, Picardi A, Bonifazi F, Saccardi R, Faraci M, Grillo G, Farina L, Bruno B, Grassi A, Proia A, Tagliaferri E, De Simone G, Malagola M, Cerno M, Cesaro S, Bernasconi P, Prezioso L, Carluccio P, Mordini N, Pelosini M, Olivieri A, Chiusolo P, Santarone S, Cimminiello M, Crocchiolo R, Papola F, Rombolà G, Sacchi N, Miotti V, Mele L, Mazzi B, Ciceri F, Martino M, Iori AP. La Rocca U, et al. Among authors: oldani e. Blood Transfus. 2025 Mar;23(2):176-185. doi: 10.2450/BloodTransfus.790. Epub 2025 Jan 28. Blood Transfus. 2025. PMID: 39949023 Free PMC article.
Clinical impact of tyrosine kinases related mutations in NPM1 mutated acute myeloid leukaemia: A report from the Northern Italy Leukaemia Group (NILG) multicentre randomized trial 02/06.
Cavallaro G, Salmoiraghi S, Cavagna R, Pavoni C, Belotti C, Milani M, Oldani E, Frigeni M, Intermesoli T, Grassi A, Bassan R, Spinelli O, Rambaldi A, Lussana F. Cavallaro G, et al. Among authors: oldani e. Leuk Res. 2025 Jun;153:107702. doi: 10.1016/j.leukres.2025.107702. Epub 2025 Apr 20. Leuk Res. 2025. PMID: 40286636 Clinical Trial.
Real-world study in steroid-refractory acute graft versus host disease: Comparison of efficacy and tolerability of ruxolitinib alone or ruxolitinib in association with extracorporeal photopheresis or extracorporeal photopheresis monotherapy.
Battista ML, Facchin G, De Martino M, Chiusolo P, Russo D, Malagola M, Saraceni F, Mancini G, Rambaldi A, Cavattoni IM, Lico A, Nozzoli C, Cuoghi A, Ladetto M, Federico V, Micò MC, Lupo-Stanghellini MT, Oldani E, Degrandi E, Gallina AM, Parma M, Biffi A, Fagioli F, Skert C, Geromin A, Savignano C, Isola M, Fanin R, Ciceri F, Martino M, Patriarca F. Battista ML, et al. Among authors: oldani e. Bone Marrow Transplant. 2025 Oct;60(10):1406-1409. doi: 10.1038/s41409-025-02674-3. Epub 2025 Jul 26. Bone Marrow Transplant. 2025. PMID: 40715542 No abstract available.
Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE).
Snowden JA, Saccardi R, Orchard K, Ljungman P, Duarte RF, Labopin M, McGrath E, Brook N, de Elvira CR, Gordon D, Poirel HA, Ayuk F, Beguin Y, Bonifazi F, Gratwohl A, Milpied N, Moore J, Passweg J, Rizzo JD, Spellman SR, Sierra J, Solano C, Sanchez-Guijo F, Worel N, Gusi A, Adams G, Balan T, Baldomero H, Macq G, Marry E, Mesnil F, Oldani E, Pearce R, Perry J, Raus N, Schanz U, Tran S, Wilcox L, Basak GW, Chabannon C, Corbacioglu S, Dolstra H, Kuball J, Mohty M, Lankester A, Montoto S, Nagler A, Styczynski J, Yakoub-Agha I, de Latour RP, Kroeger N, Brand R, de Wreede LC, van Zwet E, Putter H. Snowden JA, et al. Among authors: oldani e. Bone Marrow Transplant. 2020 Apr;55(4):681-694. doi: 10.1038/s41409-019-0718-7. Epub 2019 Oct 21. Bone Marrow Transplant. 2020. PMID: 31636397 Free PMC article. Review.
Allelic HLA Matching and Pair Origin Are Favorable Prognostic Factors for Unrelated Hematopoietic Stem Cell Transplantation in Neoplastic Hematologic Diseases: An Italian Analysis by the Gruppo Italiano Trapianto di Cellule Staminali e Terapie Cellulari, Italian Bone Marrow Donor Registry, and Associazione Italiana di Immunogenetica e Biologia dei Trapianti.
Picardi A, Sacchi N, Miotti V, Lorentino F, Oldani E, Rambaldi A, Sessa M, Bruno B, Cerno M, Vago L, Bernasconi P, Arcese W, Benedetti F, Pioltelli P, Russo D, Farina L, Fagioli F, Guidi S, Saporiti G, Zallio F, Chiusolo P, Borghero C, Papalinetti G, La Rocca U, Milone G, Lamparelli T, Carella AM, Luppi M, Olivieri A, Martino M, Carluccio P, Celeghini I, Andreani M, Gallina AM, Patriarca F, Pollichieni S, Mammoliti S, Miccichè S, Mangione I, Ciceri F, Bonifazi F. Picardi A, et al. Among authors: oldani e. Transplant Cell Ther. 2021 May;27(5):406.e1-406.e11. doi: 10.1016/j.jtct.2020.11.021. Epub 2021 Feb 16. Transplant Cell Ther. 2021. PMID: 33965179 Free article.
Novel Drug Combinations and Donor Lymphocyte Infusions Allow Prolonged Disease Control in Multiple Myeloma Patients Relapsing after Allogeneic Transplantation.
Nozzoli C, Pucillo M, Giaccone L, Rambaldi A, Stanghellini MTL, Benedetti E, Russo D, Mordini N, Mangiacavalli S, Bernasconi P, Parma M, Carluccio P, Galieni P, Rivela P, Martino M, Chiusolo P, Isola M, De Martino M, Oldani E, Degrandi E, Boncompagni R, Antonioli E, Carnevale F, Tozzi M, Selleri C, Fanin R, Patriarca F; Gruppo Italiano Trapianto Midollo Osseo (GITMO). Nozzoli C, et al. Among authors: oldani e. Transplant Cell Ther. 2025 Jan;31(1):26.e1-26.e13. doi: 10.1016/j.jtct.2024.10.015. Epub 2024 Nov 4. Transplant Cell Ther. 2025. PMID: 39505212
67 results